FR2025241A1 - Vaccine for foot and mouth disease and brucellosis - Google Patents

Vaccine for foot and mouth disease and brucellosis

Info

Publication number
FR2025241A1
FR2025241A1 FR6941934A FR6941934A FR2025241A1 FR 2025241 A1 FR2025241 A1 FR 2025241A1 FR 6941934 A FR6941934 A FR 6941934A FR 6941934 A FR6941934 A FR 6941934A FR 2025241 A1 FR2025241 A1 FR 2025241A1
Authority
FR
France
Prior art keywords
foot
vaccine
brucellosis
mouth disease
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR6941934A
Other languages
French (fr)
Other versions
FR2025241B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Publication of FR2025241A1 publication Critical patent/FR2025241A1/en
Application granted granted Critical
Publication of FR2025241B1 publication Critical patent/FR2025241B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Vaccine comprises an aq. suspn. of anti-foot-and mouth disease (FMD) antigens and anti-brucellosis antigens, opt. together with an adjuvant. In certain circumstances, a trivalent vaccine contg. anti-rabies antigens may be prepd.
FR6941934A 1968-12-04 1969-12-04 Vaccine for foot and mouth disease and brucellosis Granted FR2025241A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU57465 1968-12-04

Publications (2)

Publication Number Publication Date
FR2025241A1 true FR2025241A1 (en) 1970-09-04
FR2025241B1 FR2025241B1 (en) 1974-02-01

Family

ID=19725813

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6941934A Granted FR2025241A1 (en) 1968-12-04 1969-12-04 Vaccine for foot and mouth disease and brucellosis

Country Status (8)

Country Link
BE (1) BE742586A (en)
BR (1) BR6914736D0 (en)
DE (1) DE1960713C3 (en)
ES (1) ES374182A1 (en)
FR (1) FR2025241A1 (en)
IT (1) IT1043791B (en)
LU (1) LU57465A1 (en)
NL (1) NL6918177A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2516385A1 (en) * 1981-11-19 1983-05-20 Merieux Inst ANTI-APHTEOUS AND ANTI-COLIBACILLARY VACCINE AND METHOD FOR PREPARING THE SAME
EP0129923A1 (en) * 1983-06-06 1985-01-02 Duphar International Research B.V Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
FR2577139A1 (en) * 1985-02-10 1986-08-14 Israel Mini Agricult VACCINE COMPOSITION AND METHOD OF PREPARATION

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979503B (en) * 2010-10-13 2012-05-23 中国兽医药品监察所 Recombinant brucella for expressing Asia type-I foot and mouth disease virus VP1 genes and method for producing vaccines thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1229677B (en) * 1963-10-25 1966-12-01 Nat Res Dev Process for the preparation of injectable emulsions containing antigens

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2516385A1 (en) * 1981-11-19 1983-05-20 Merieux Inst ANTI-APHTEOUS AND ANTI-COLIBACILLARY VACCINE AND METHOD FOR PREPARING THE SAME
EP0080412A1 (en) * 1981-11-19 1983-06-01 Rhone Merieux Vaccine against foot-and-mouth disease and colibacillosis, and process for preparing it
EP0129923A1 (en) * 1983-06-06 1985-01-02 Duphar International Research B.V Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
FR2577139A1 (en) * 1985-02-10 1986-08-14 Israel Mini Agricult VACCINE COMPOSITION AND METHOD OF PREPARATION

Also Published As

Publication number Publication date
LU57465A1 (en) 1970-06-04
ES374182A1 (en) 1972-04-01
BR6914736D0 (en) 1973-02-08
BE742586A (en) 1970-06-03
DE1960713C3 (en) 1981-12-17
IT1043791B (en) 1980-02-29
FR2025241B1 (en) 1974-02-01
DE1960713A1 (en) 1970-06-18
NL6918177A (en) 1970-06-08

Similar Documents

Publication Publication Date Title
BE771918A (en) VAPORIZED VACCINES
DK114289B (en) Process for the preparation of an inactivated vaccine against swine cholera.
BE787901A (en) ANTIVARIOLIC VACCINE
TR17729A (en) MEDICAL YEAST DELIVERY DEVICE AND PROCEDURE FOR GIVING MANY MEDICAL MINE
FR2025241A1 (en) Vaccine for foot and mouth disease and brucellosis
IT941778B (en) MOUTH MUCOSA INSERT
IL30168A0 (en) Antigen-free vaccine and process for preparing it
GR36834B (en) METHOD AND COMPOSITIONS FOR THE INTRODUCTION OF ALCOXYVENZAMIDE IN THE CIRCULATORY SYSTEM.
BE781028R (en) ADJUVANTS FOR VACCINES AND VACCINE PREPARATIONS
IL29925A0 (en) Tetanus vaccine and process for preparing it
SE7608007L (en) INTRAVENOST POPULAR PUPPY DISEASE AND HEPATITIS VACCINE, PROCEDURE FOR ITS MANUFACTURE AND ITS USE FOR IMMUNIZATION
CH558170A (en) PNEUMATICALLY DRIVEN DENTAL HANDPIECE.
DK121529B (en) Dental and oral care product and method for its manufacture.
FR2774M (en) Somatic antigen vaccines.
BE771536A (en) PREPARING A VACCINE
FI46863C (en) Method for preparing an influenza vaccine comprising an antigen, an adjuvant and a polynucleotide
IT981940B (en) PROCEDURE FOR TRANSPORTING A PREFIXED POSITION IN COLAR PARTS OF PARTS OF THERMAL PLASTIC DRAWN LAMINATE
CA1007567A (en) Vaccine adjuvants
IT7830643A0 (en) TYPHOUS VACCINE AND PROCEDURE FOR ITS PREPARATION.
IL39360A (en) Vaccine containing isozyme ldh-x and method for immunological contraception in male animals
IL27927A (en) Process for cultivating foot and mouth disease virus
CA999523B (en) Immunizing vaccine against kennel cough
AU426741B2 (en) Process for preparing a shipping fever vaccine and use ofthe vaccine in immunizing cattle
CA888153A (en) Antigen-free vaccine and process for preparing it
GR33846B (en) ORIGINAL PLASTIC PUMP (PUMP), ADAPTED TO THE BOTTLE MOUTH, FOR THE LAUNCH OF THE CONTENT OF THE FORMAT IN THE FORM.

Legal Events

Date Code Title Description
ST Notification of lapse